Used in research as a reactivator of the p53 tumor suppressor protein, particularly in cancers with specific p53 mutations. Shows potential in targeting zinc-deficient mutant p53, restoring its normal function and inducing cancer cell death. Investigated for its anticancer properties in preclinical studies, especially in tumors resistant to conventional therapies. Also serves as a tool compound in studying p53 pathway modulation and zinc metallochaperone activity.